Stock Research: Staar Surgical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Staar Surgical

NasdaqGM:STAA US8523123052
4
  • Value
    27
  • Growth
    59
  • Safety
    Safety
    16
  • Combined
    9
  • Sentiment
    12
  • 360° View
    360° View
    4
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye. The company operates in the medical devices industry, with a focus on refractive surgery. STAAR Surgical Company markets and sells its ICLs globally. In the last fiscal year, the company had a market cap of $853 million, profits of $240 million, and revenue of $314 million, with 1157 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 4 (better than 4% compared with alternatives), overall professional sentiment and financial characteristics for the stock Staar Surgical are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Staar Surgical. The consolidated Growth Rank has a good rank of 59, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 59% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 16 means that the share price of Staar Surgical is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 84% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 27, which means that the company has a riskier financing structure than 73% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 12, indicating professional investors are more pessimistic about the stock than for 88% of alternative investment opportunities. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
16 41 33 3
Growth
59 19 59 95
Safety
Safety
27 100 96 94
Sentiment
12 21 58 98
360° View
360° View
4 94 91 94
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
9 18 24 50
Opinions Change
50 5 50 50
Pro Holdings
n/a 35 44 94
Market Pulse
28 81 97 100
Sentiment
12 21 58 98
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
16 41 33 3
Growth
59 19 59 95
Safety Safety
27 100 96 94
Combined
9 68 84 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
50 38 28 20
Price vs. Earnings (P/E)
17 41 36 13
Price vs. Book (P/B)
26 59 45 8
Dividend Yield
1 1 1 1
Value
16 41 33 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
92 91 49 65
Profit Growth
4 4 78 100
Capital Growth
71 16 77 73
Stock Returns
45 19 33 59
Growth
59 19 59 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
86 85 74 79
Refinancing
35 69 35 15
Liquidity
1 100 98 98
Safety Safety
27 100 96 94

Similar Stocks

Discover high‑ranked alternatives to Staar Surgical and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Intuit

NasdaqGS:INTU
Country: USA
Industry: Application Software
Size: X-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.